5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Transitioning to Country Ownership of HIV Programs in Rwanda

      other

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Agnes Binagwaho and colleagues describe how Rwanda achieved country ownership of its HIV programs.

          Related collections

          Most cited references8

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Reduced premature mortality in Rwanda: lessons from success

          Some errors went uncorrected in the table of this article by Paul Farmer and colleagues (BMJ 2013;346:f65, doi:10.1136/bmj.f65). The figures for malaria were incorrect, the subheadings wrongly appeared at the top of the table, and the source references should have been 2, 33, 34, 35, and 36. The correct table is here. In addition, the affiliation for Soline Dusabeyesu Mugeni should be the Clinton Health Access Initiative [not Partners in Health]. Table Premature mortality in Rwanda, 2000-112 33 34 35 36 2000 2011 Total reduction (%) Annual rate of reduction (%) Regional rank Global rank* HIV/AIDS HIV incidence/ 100 000 207 88† 57.5 9.5 5 8 AIDS deaths/100 000 190 41† 78.4 17.0 1 1 Tuberculosis Incidence/100 000 326 94 71.2 11.3 1 4 Mortality/100 000 48 11 77.1 13.4 1 5 Malaria Total cases 1 654 246‡ 208 858 87.4 34.45 NA NA Total deaths 2 581‡ 380 85.3 31.9 NA NA Child and maternal mortality Deaths/1000 live births 183 54 70.4 11.1 1 1 Total deaths 61343 22 813 62.8 9.0 2 4 Maternal mortality ratio/100 000 live births 840 340§ 59.5 9.0 1 6 *Only countries with populations greater than 500 000 included. †2009 data. ‡2005 data. §2010 data.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            How the Avahan HIV prevention program transitioned from the Gates Foundation to the government of India.

            Developing countries face diminishing development aid and time-limited donor commitments that challenge the long-term sustainability of donor-funded programs to improve the health of local populations. Increasing country ownership of the programs is one solution. Transitioning managerial and financial responsibility for donor-funded programs to governments and local stakeholders represents a highly advanced form of country ownership, but there are few successful examples among large-scale programs. We present a transition framework and describe how it was used to transfer the Bill & Melinda Gates Foundation's HIV/AIDS prevention program, the Avahan program, to the Government of India. Essential features recommended for the transition of donor-funded programs to governments include early planning with the government, aligning donor program components with government structures and funding models prior to transition, building government capacity through active technical and management support, budgeting for adequate support during and after the transition, and dividing the transition into phases to allow time for adjustments and corrections. The transition of programs to governments is an important sustainability strategy for efforts to scale up HIV prevention programs to reach the populations most at risk.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              PEPFAR, health system strengthening, and promoting sustainability and country ownership.

              Evidence demonstrates that scale-up of HIV services has produced stronger health systems and, conversely, that stronger health systems were critical to the success of the HIV scale-up. Increased access to and effectiveness of HIV treatment and care programs, attention to long-term sustainability, and recognition of the importance of national governance, and country ownership of HIV programs have resulted in an increased focus on structures that compromise the broader health system. Based on a review published literature and expert opinion, the article proposes 4 key health systems strengthening issues as a means to promote sustainability and country ownership of President's Emergency Plan for AIDS Relief and other global health initiatives. First, development partners need provide capacity building support and to recognize and align resources with national government health strategies and operational plans. Second, investments in human capital, particularly human resources for health, need to be guided by national institutions and supported to ensure the training and retention of skilled, qualified, and relevant health care providers. Third, a range of financing strategies, both new resources and improved efficiencies, need to be pursued as a means to create more fiscal space to ensure sustainable and self-reliant systems. Finally, service delivery models must adjust to recent advancements in areas of HIV prevention and treatment and aim to establish evidence-based delivery models to reduce HIV transmission rates and the overall burden of disease. The article concludes that there needs to be ongoing efforts to identify and implement strategic health systems strengthening interventions and address the inherent tension and debate over investments in health systems.
                Bookmark

                Author and article information

                Journal
                PLoS Med
                PLoS Med
                plos
                plosmed
                PLoS Medicine
                Public Library of Science (San Francisco, CA USA )
                1549-1277
                1549-1676
                9 August 2016
                August 2016
                : 13
                : 8
                : e1002075
                Affiliations
                [1 ]Rwanda Ministry of Health, Kigali, Rwanda
                [2 ]Harvard Medical School, Boston, Massachusetts, United States of America
                [3 ]Geisel School of Medicine – Dartmouth, Hanover, New Hampshire, United States of America
                [4 ]Division of Global HIV/AIDS, Centers for Disease Control and Prevention, Kigali, Rwanda
                [5 ]CTS Global Services, Los Angeles, California, United States of America
                [6 ]ICAP at Columbia University, Mailman School of Public Health, Columbia University, New York, New York, United States of America
                [7 ]AIDSRelief, Catholic Relief Services, Kigali, Rwanda
                [8 ]Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
                Author notes

                AB is a member of the Editorial Board of PLOS Medicine.

                Contributed to the writing of the manuscript: AB IK EK JPN SN FM RKK VM RS CB LI AA WMES PLR KWS. Wrote the first draft of the manuscript: AB IK EK PLR. Agree with the manuscript’s results and conclusions: AB IK EK JPN SN FM RKK VM RS CB LI AA WMES PLR KWS. All authors have read, and confirm that they meet, ICMJE criteria for authorship.

                Author information
                http://orcid.org/0000-0002-6779-3151
                http://orcid.org/0000-0003-1305-2208
                http://orcid.org/0000-0002-2159-4800
                http://orcid.org/0000-0002-0180-1649
                Article
                PMEDICINE-D-15-01386
                10.1371/journal.pmed.1002075
                4978459
                27505355
                bb2df88d-78ae-41b5-8f62-0b031f405135

                This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

                History
                Page count
                Figures: 1, Tables: 1, Pages: 8
                Funding
                This article was supported by Cooperative Agreement No. 1U2GPS002091 from the US President’s Emergency Plan for AIDS Relief through the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of PEPFAR and the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
                Categories
                Policy Forum
                Biology and Life Sciences
                Microbiology
                Medical Microbiology
                Microbial Pathogens
                Viral Pathogens
                Immunodeficiency Viruses
                HIV
                Medicine and Health Sciences
                Pathology and Laboratory Medicine
                Pathogens
                Microbial Pathogens
                Viral Pathogens
                Immunodeficiency Viruses
                HIV
                Biology and Life Sciences
                Organisms
                Viruses
                Viral Pathogens
                Immunodeficiency Viruses
                HIV
                Biology and Life Sciences
                Organisms
                Viruses
                Immunodeficiency Viruses
                HIV
                Biology and life sciences
                Organisms
                Viruses
                RNA viruses
                Retroviruses
                Lentivirus
                HIV
                Biology and Life Sciences
                Microbiology
                Medical Microbiology
                Microbial Pathogens
                Viral Pathogens
                Retroviruses
                Lentivirus
                HIV
                Medicine and Health Sciences
                Pathology and Laboratory Medicine
                Pathogens
                Microbial Pathogens
                Viral Pathogens
                Retroviruses
                Lentivirus
                HIV
                Biology and Life Sciences
                Organisms
                Viruses
                Viral Pathogens
                Retroviruses
                Lentivirus
                HIV
                People and Places
                Geographical Locations
                Africa
                Rwanda
                Medicine and health sciences
                Diagnostic medicine
                HIV diagnosis and management
                Medicine and Health Sciences
                Health Care
                Health Care Policy
                Health Systems Strengthening
                Medicine and Health Sciences
                Infectious Diseases
                Viral Diseases
                AIDS
                Medicine and health sciences
                Epidemiology
                HIV epidemiology
                Medicine and health sciences
                Public and occupational health
                Preventive medicine
                HIV prevention
                Medicine and Health Sciences
                Health Care
                Health Care Policy

                Medicine
                Medicine

                Comments

                Comment on this article